(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Solar storms have influenced our history – an environmental historian explains how they could also threaten our future - 2Flu is rising rapidly, driven by a new variant. Here's what to know
- 3Bruno Mars tour 2026: How to get tickets for 'The Romantic Tour,' presale times, prices and more
- 4Figure out How to Adjust Your Handshake to Various Societies
- 5JFK's granddaughter reveals terminal cancer diagnosis, criticizes cousin RFK Jr.
- Support Your Wellness: 20-Minute Home Exercises That Work
- 6 Agreeable Earphones To Wear
- Massive supernova explosion may have created a binary black hole
- Careful Nurturing: Techniques for Bringing up Tough Children
- The 10 Most Famous Style Minutes on Honorary pathway
- How did Ariana Grande get her Glinda voice? I’m the man behind the magic.
- What’s the shadowy organisation taking Gaza Palestinians to South Africa?
- RFK Jr.’s vaccine advisers plan biggest change yet to childhood schedule
- Go With The Breeze: Grand Paragliding Spots On the planet
